Penn. paying for counter-detailing
“If you just practice smart, you'll be able to give better care and, by the way, save money,” Avorn said. He first developed an academic detailing program 25 years ago while in medical school.
Sandoz counsel argued that Amgen's position "wrongly delays the marketing of every biosimilar."
Some leaders have stepped up, and this serves their companies - and the industry - well.
A study published in Health Affairs detailed an outcomes-based pilot developed by the drugmaker and Priority Health, a Michigan-based health insurer.